Novo Nordisk increasing supply of Wegovy as demand continues to grow

For the first time since May, Novo Nordisk is gradually increasing the supply of its highly sought-after weight loss drug Wegovy. The Danish drugmaker told FOX Business the company is making significant investments in Wegovy, which gained significant attention since 2022 after being touted by high-profile figures and social media users for its weight loss effects. It "has been steadily increasing capacity to produce more Wegovy than ever before," the company said.  NOVO NORDISK'S WEGOVY REDUCES RISK OF SERI ...